News

AB Science receives US FDA & EMA authorization for confirmatory phase 3 trial of masitinib in metastatic castrate resistant prostate cancer: Paris Monday, July 7, 2025, 11:00 Hrs ...
Everest Medicines unveils breakthroughs in AI+mRNA platform, reinforces global leadership in next-gen mRNA innovation: Hong Kong Monday, July 7, 2025, 10:00 Hrs [IST] Everest Medi ...
DCC gives nod to amend Rules related to licensing of stem cell derived & gene therapy products: Gireesh Babu, New Delhi Monday, July 7, 2025, 08:00 Hrs [IST] The Drugs Consultativ ...
EMA & HMA issue recommendations to address vulnerabilities in the supply chain of anti-D immunoglobulins: Amsterdam, The Netherlands Monday, July 7, 2025, 09:00 Hrs [IST] The Euro ...
Pharmexcil invites Croatia and Austria pharma delegation to explore iPHEX -2025 to enhance bilateral trade: Shardul Nautiyal, Mumbai Monday, July 7, 2025, 08:00 Hrs [IST] With rep ...
Imports of bulk drugs and intermediates to India have seen a decline for the second consecutive month in FY26, and a cumulative decline for the first two months of the fiscal year. The imports ...
Indian healthcare sector grapples with acute shortages of infrastructure & skilled professionals: Dr Raj Nagarkar: Nandita Vijayasimha, Bengaluru Saturday, July 5, 2025, 08:00 Hrs ...
The Union government's substantial and commendable support for the Indian pharmaceutical industry, particularly for the MSME sector, is evident. T. Revichandran, vice-president of IDMA South Region, ...
DCC recommends DCGI to share SOPs and formats with States as per IDP: Gireesh Babu, New Delhi Saturday, July 5, 2025, 08:00 Hrs [IST] The Drugs Consultative Committee (DCC) has re ...